TRxADE HEALTH To Acquire Superlatus, Inc.; Superlatus Shareholders To Receive ~30.82M Shares Of MEDS
Portfolio Pulse from Bill Haddad
TRxADE HEALTH, Inc. (NASDAQ:MEDS) has signed a binding letter of intent to acquire Superlatus, Inc., a US-based holding company of food products and distribution capabilities. Upon closing, Superlatus shareholders will receive 30,821,918 shares of MEDS, valued at $7.30 per share.
June 23, 2023 | 12:07 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
TRxADE HEALTH (NASDAQ:MEDS) is set to acquire Superlatus, Inc., with Superlatus shareholders receiving 30,821,918 shares of MEDS, valued at $7.30 per share.
The acquisition of Superlatus by TRxADE HEALTH could potentially expand the company's product offerings and distribution capabilities. However, the short-term impact on MEDS stock price is uncertain as the market may need time to digest the news and evaluate the potential benefits of the acquisition.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100